‘Significant discrepancies’ in imported melatonin content


TGA flags concerns over imported melatonin products following laboratory testing  Patients are being urged to stop using imported unregistered melatonin, after the Therapeutic Goods Administration (TGA) found one product contained four times the labelled content.   TGA Laboratories’ testing found eight products contained more melatonin than advertised on the packaging, while three others had lower

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘Misinformation spreads faster and further than truth’
Next TGA dismisses Vyvanse concerns